Plexus (NASDAQ:PLXS) PT Raised to $95.00 at Stifel Nicolaus

Plexus (NASDAQ:PLXS) had its target price increased by Stifel Nicolaus from $90.00 to $95.00 in a report released on Friday, Benzinga reports. Stifel Nicolaus currently has a hold rating on the technology company’s stock.

PLXS has been the topic of a number of other research reports. TheStreet downgraded Plexus from a b rating to a c+ rating in a report on Tuesday, February 13th. Sidoti downgraded Plexus from a buy rating to a neutral rating and set a $112.00 target price on the stock. in a report on Tuesday, January 9th. Needham & Company LLC increased their target price on Plexus from $107.00 to $114.00 and gave the stock a buy rating in a report on Friday. Finally, Benchmark reaffirmed a buy rating and set a $110.00 target price on shares of Plexus in a report on Wednesday, January 17th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of Hold and a consensus price target of $107.75.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $100.28 on Friday. Plexus has a fifty-two week low of $83.84 and a fifty-two week high of $114.06. The business has a 50 day moving average price of $94.48 and a two-hundred day moving average price of $98.41. The company has a quick ratio of 0.62, a current ratio of 1.51 and a debt-to-equity ratio of 0.15. The firm has a market cap of $2.77 billion, a PE ratio of 27.70 and a beta of 1.02.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings data on Wednesday, April 24th. The technology company reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.07. Plexus had a return on equity of 10.77% and a net margin of 2.54%. The firm had revenue of $966.90 million during the quarter, compared to analyst estimates of $950.75 million. During the same quarter last year, the firm earned $1.45 EPS. Plexus’s quarterly revenue was down 9.7% on a year-over-year basis. Sell-side analysts expect that Plexus will post 4.36 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CAO Angelo Michael Ninivaggi, Jr. sold 3,694 shares of the firm’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $97.18, for a total value of $358,982.92. Following the sale, the chief accounting officer now owns 40,875 shares of the company’s stock, valued at approximately $3,972,232.50. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other Plexus news, insider Michael J. Running sold 542 shares of Plexus stock in a transaction on Tuesday, January 30th. The stock was sold at an average price of $95.60, for a total transaction of $51,815.20. Following the sale, the insider now owns 1,569 shares of the company’s stock, valued at approximately $149,996.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Angelo Michael Ninivaggi, Jr. sold 3,694 shares of Plexus stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $97.18, for a total value of $358,982.92. Following the sale, the chief accounting officer now directly owns 40,875 shares in the company, valued at approximately $3,972,232.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,453 shares of company stock valued at $3,112,875. Insiders own 2.39% of the company’s stock.

Institutional Trading of Plexus

Several hedge funds have recently added to or reduced their stakes in the business. Inspire Investing LLC raised its stake in Plexus by 3.6% during the 3rd quarter. Inspire Investing LLC now owns 3,323 shares of the technology company’s stock valued at $309,000 after acquiring an additional 114 shares in the last quarter. Parallel Advisors LLC raised its stake in Plexus by 72.3% during the 4th quarter. Parallel Advisors LLC now owns 348 shares of the technology company’s stock valued at $38,000 after acquiring an additional 146 shares in the last quarter. Congress Asset Management Co. MA raised its stake in Plexus by 1.1% during the 1st quarter. Congress Asset Management Co. MA now owns 16,273 shares of the technology company’s stock valued at $1,543,000 after acquiring an additional 184 shares in the last quarter. Moran Wealth Management LLC raised its stake in Plexus by 0.5% during the 4th quarter. Moran Wealth Management LLC now owns 48,809 shares of the technology company’s stock valued at $5,278,000 after acquiring an additional 230 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Plexus by 6.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,267 shares of the technology company’s stock valued at $678,000 after purchasing an additional 363 shares during the period. Institutional investors own 94.45% of the company’s stock.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.